Baillie Gifford acquired 67.5 Thousand Charles River Laboratories International shares worth $14.2 Million. That's 0.01% of their equity portfolio (199th largest holding). The first Charles River Laboratories International trade was made in Q2 2022. Since then Baillie Gifford bought shares two more times and sold shares on five occasions. The investor's estimated purchase price is $15.1 Million, resulting in a loss of 5.9%.